Page 5 - Marcel Konrad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medexus Pharmaceuticals Inc : Medexus to Participate in the LD Micro Invitational XIII

Toronto, Ontario and Chicago, Illinois (Newsfile Corp. - June 1, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the

United statesSouth australiaMarcel konradMedexus pharmaceuticalsIllinois newsfile corpLuxe sunset boulevard hotelChief executive officerChief financial officerNorth american

Medexus to Participate in the LD Micro Invitational XIII

Medexus to Participate in the LD Micro Invitational XIII
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South australiaUnited statesMarcel konradIllinois newsfile corpMedexus pharmaceuticalsWall streetLuxe sunset boulevard hotelChief executive officerChief financial officerNorth american

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth australiaMarcel konradToronto stock exchangeIllinois newsfile corpMedexus pharmaceuticalsChief executiveChief financialNorth american

Medexus Pharmaceuticals Inc : Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures

NCIB will commence on May 15, 2023 and is expected to continue through the debentures' October 2023 maturity dateNCIB purchases will deleverage Medexus's balance sheet and lead to lower overall debt levels

United statesSouth australiaMarcel konradToronto stock exchangeIllinois newsfile corpMedexus pharmaceuticalsChief executiveChief financialNorth americanGefallene big techs

Medexus gets a target increase from Raymond James

Québec-based specialty pharma company Medexus Pharmaceuticals received a target price increase from Raymond James on Thursday after securing a new bank debt.

Rahul sarugaserMarcel konradMedexus pharmaceuticals stockMedexus pharmaceuticalsMedexus pharmaceuticals stock quoteRaymond jamesAnalyst rahul sarugaser